Literature DB >> 1364815

Akathisia, suicidality, and fluoxetine.

M S Hamilton1, L A Opler.   

Abstract

BACKGROUND: The propose link between fluoxetine and suicidal ideation is explained by fluoxetine-induced akathisia and other dysphoric extrapyramidal reactions.
METHOD: The following literature is reviewed: (1) the subjective response of schizophrenics to akathisia, including evidence that akathisia gives rise to suicidal ideation; (2) the subjective reports of patients taking fluoxetine; and (3) preclinical studies describing the role of serotonin in the extrapyramidal system and suggesting a mechanism whereby fluoxetine can induce extrapyramidal side effects.
RESULTS: The literature suggests that fluoxetine-induced extrapyramidal reactions may be a mediator of de novo suicidal ideation.
CONCLUSION: We propose a syndrome which we name Extrapyramidal-Induced Dysphoric Reactions, one extreme manifestation of which is the emergence of suicidal ideation. We further propose a heuristic "Four Neuron Model of the Extrapyramidal Motor System" in which increased serotonin activity, by inhibiting the nigrostriatal dopamine tract, is capable of inducing extrapyramidal side effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1364815

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  The syndrome of motor restlessness--a treatable but under-recognised disorder.

Authors:  A Bakheit
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

3.  Markers of basal ganglia dysfunction and conversion to psychosis: neurocognitive deficits and dyskinesias in the prodromal period.

Authors:  Vijay A Mittal; Elaine F Walker; Carrie E Bearden; Deborah Walder; Hanan Trottman; Melita Daley; Anthony Simone; Tyrone D Cannon
Journal:  Biol Psychiatry       Date:  2010-03-15       Impact factor: 13.382

4.  Extrapyramidal side effects and suicidal ideation under fluoxetine treatment: a case report.

Authors:  Christos Christodoulou; Athanasia Papadopoulou; Emmanouil Rizos; Kalliopi Tournikioti; Xenia Gonda; Athanassios Douzenis; Lefteris Lykouras
Journal:  Ann Gen Psychiatry       Date:  2010-01-18       Impact factor: 3.455

5.  Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.

Authors:  Matthew Miller; V Pate; S A Swanson; D Azrael; A White; T Stürmer
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 6.  Comparative tolerability profiles of the newer versus older antidepressants.

Authors:  M V Rudorfer; H K Manji; W Z Potter
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.